메뉴 건너뛰기




Volumn 19, Issue 3, 2014, Pages 283-289

Evacetrapib at a supratherapeutic steady state concentration does not prolong QT in a thorough QT/QTc study in healthy participants

Author keywords

cholesteryl ester transfer protein; evacetrapib; QT interval

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ENOXAPARIN; EVACETRAPIB; MOXIFLOXACIN; PLACEBO; WARFARIN; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; CHOLESTEROL ESTER TRANSFER PROTEIN; QUINOLONE DERIVATIVE;

EID: 84898937203     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248413510784     Document Type: Article
Times cited : (10)

References (11)
  • 1
    • 0023029454 scopus 로고
    • Incidence of coronary heart disease and lipoprotein cholesterol levels. the Framingham study
    • Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. JAMA. 1986 ; 256 (20). 2835-2838
    • (1986) JAMA , vol.256 , Issue.20 , pp. 2835-2838
    • Castelli, W.P.1    Garrison, R.J.2    Wilson, P.W.3    Abbott, R.D.4    Kalousdian, S.5    Kannel, W.B.6
  • 2
    • 0035962077 scopus 로고    scopus 로고
    • Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: A randomized controlled trial
    • Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA. 2001 ; 285 (12). 1585-1591
    • (2001) JAMA , vol.285 , Issue.12 , pp. 1585-1591
    • Robins, S.J.1    Collins, D.2    Wittes, J.T.3
  • 3
    • 0035969564 scopus 로고    scopus 로고
    • Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
    • Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001 ; 345 (22). 1583-1592
    • (2001) N Engl J Med , vol.345 , Issue.22 , pp. 1583-1592
    • Brown, B.G.1    Zhao, X.Q.2    Chait, A.3
  • 4
    • 0035293881 scopus 로고    scopus 로고
    • Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes
    • Owens RC. Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes. Pharmacotherapy. 2001 ; 21 (3). 301-319
    • (2001) Pharmacotherapy , vol.21 , Issue.3 , pp. 301-319
    • Owens, R.C.1
  • 5
    • 84870045994 scopus 로고    scopus 로고
    • Effects of dalcetrapib in patients with a recent acute coronary syndrome
    • Schwartz GG, Olsson AG, Abt M, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012 ; 367 (22). 2089-2099
    • (2012) N Engl J Med , vol.367 , Issue.22 , pp. 2089-2099
    • Schwartz, G.G.1    Olsson, A.G.2    Abt, M.3
  • 6
    • 77955554815 scopus 로고    scopus 로고
    • Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing
    • Derks M, Abt M, Mwangi A, Meneses-Lorente G. Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing. Eur J Clin Pharmacol. 2010 ; 66 (8). 775-783
    • (2010) Eur J Clin Pharmacol , vol.66 , Issue.8 , pp. 775-783
    • Derks, M.1    Abt, M.2    Mwangi, A.3    Meneses-Lorente, G.4
  • 7
    • 84970602731 scopus 로고
    • Experimental designs balanced for the estimation of residual effects of treatments
    • Williams EJ. Experimental designs balanced for the estimation of residual effects of treatments. Aust J Chem. 1949 ; 2 (2). 149-168
    • (1949) Aust J Chem , vol.2 , Issue.2 , pp. 149-168
    • Williams, E.J.1
  • 8
    • 50349099149 scopus 로고    scopus 로고
    • The effect of moxifloxacin on QTc and implications for the design of thorough QT studies
    • Bloomfield DM, Kost JT, Ghosh K, et al. The effect of moxifloxacin on QTc and implications for the design of thorough QT studies. Clin Pharmacol Ther. 2008 ; 84 (4). 475-480
    • (2008) Clin Pharmacol Ther , vol.84 , Issue.4 , pp. 475-480
    • Bloomfield, D.M.1    Kost, J.T.2    Ghosh, K.3
  • 9
    • 23844475352 scopus 로고    scopus 로고
    • Pharmaceutical Research and Manufacturers of America QT Statistics Expert Working Team. Investigating drug-induced QT and QTc prolongation in the clinic: A review of statistical design and analysis considerations: Report from the pharmaceutical research and manufacturers of America QT statistics expert team
    • Patterson SD. Pharmaceutical Research and Manufacturers of America QT Statistics Expert Working Team. Investigating drug-induced QT and QTc prolongation in the clinic: a review of statistical design and analysis considerations: report from the pharmaceutical research and manufacturers of America QT statistics expert team. Drug Inform J. 2005 ; 39 (3). 243-266
    • (2005) Drug Inform J , vol.39 , Issue.3 , pp. 243-266
    • Patterson, S.D.1
  • 10
    • 45849106884 scopus 로고    scopus 로고
    • Sample size calculations in thorough QT studies
    • Zhang L, Dmitrienko A, Luta G. Sample size calculations in thorough QT studies. J Biopharm Stat. 2008 ; 18 (3). 468-482
    • (2008) J Biopharm Stat , vol.18 , Issue.3 , pp. 468-482
    • Zhang, L.1    Dmitrienko, A.2    Luta, G.3
  • 11
    • 45849094068 scopus 로고    scopus 로고
    • Statistical issues including design and sample size calculation in thorough QT/QTc studies
    • Zhang J, Machado SG. Statistical issues including design and sample size calculation in thorough QT/QTc studies. J Biopharm Stat. 2008 ; 18 (3). 451-467
    • (2008) J Biopharm Stat , vol.18 , Issue.3 , pp. 451-467
    • Zhang, J.1    MacHado, S.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.